Vonwicks Czelestakov Onyango: The Anticoagulation Dilemma in Ulcerative Colitis
Vonwicks Czelestakov Onyango, Internal Medicine Physician at St. Joseph Rift Valley Hospital, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in IJSRM, adding:
“Ulcerative colitis patients have a 2-3 fold increased risk of developing acute venous thromboembolic disease (DVT and PE).
This is especially true when they are in severe acute flare ups.
Which then brings in the conundrum: they need therapeutic anticoagulation (whose main risk is bleeding diatheses) yet they are presently bleeding from the acute flare up (in form of multiple episodes of bloody stools and hematochezia!).
The evidence supports offering them therapeutic anticoagulation anyway, as we discuss in this case write-up.”
Title: Acute Severe Flare-up of Ulcerative Colitis Complicated by Acute Deep Venous Thrombosis in a Rural Kenyan Hospital
Authors: Vonwicks C Onyango, Collins Paul Malalu, Nicholas Auma Auma, Anne Wambui Theuri, William Charles Fryd
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 3, 2026, 20:33Jennifer Weinstein: Happy to Share Our New Work on the Patient Experience in VWD at the NBDF Conference
-
Sep 3, 2026, 20:31Guillaume Courbon: New Publication on Erythroid-Produced FGF23 and Its Role in Anemia
-
Sep 3, 2026, 20:30Phuong Khanh Morrow: FDA Approval Marks an Important Step Forward for the PV Community
-
Sep 3, 2026, 20:29Sarah Robins: Happy to Share This Portrait Film I Voiced for the NNHHF
-
Sep 3, 2026, 20:27Mireille Muller: Europe Needs More Plasma Donors
-
Sep 3, 2026, 17:54Tareq Abadl: Extravascular Hemolysis The High-Yield Guide
-
Sep 3, 2026, 17:48Isabel Sá: Starting a New Chapter as a Clinical Scientist in Molecular Genetics and Haematology
-
Sep 3, 2026, 17:40Chiwoo Oh: AS01B Adjuvant and Long-Term Immune Reprogramming After Shingrix Vaccination
-
Sep 3, 2026, 17:35Key Developments in Transfusion Medicine and Biotherapies in 2025 – AABB